Cargando…
Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
NK cell adoptive therapy is a promising cancer therapeutic approach, but there are significant challenges that limiting its feasibility and clinical efficacy. One difficulty is the paucity of clinical grade manufacturing platforms to support the large scale expansion of highly active NK cells. We cr...
Autores principales: | Ojo, Evelyn O., Sharma, Ashish Arunkumar, Liu, Ruifu, Moreton, Stephen, Checkley-Luttge, Mary-Ann, Gupta, Kalpana, Lee, Grace, Lee, Dean A., Otegbeye, Folashade, Sekaly, Rafick-Pierre, de Lima, Marcos, Wald, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797802/ https://www.ncbi.nlm.nih.gov/pubmed/31624330 http://dx.doi.org/10.1038/s41598-019-51287-6 |
Ejemplares similares
-
Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
por: Otegbeye, Folashade, et al.
Publicado: (2018) -
Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
por: Otegbeye, Folashade, et al.
Publicado: (2018) -
Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line
por: Bae, Duk Seong, et al.
Publicado: (2014) -
Repression of GSK3 restores NK cell cytotoxicity in AML patients
por: Parameswaran, Reshmi, et al.
Publicado: (2016) -
Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity
por: Min, Bokyung, et al.
Publicado: (2021)